Form 4: BioCardia Executive Sells Shares for Tax Planning
SEC Form 4 Filing
A BioCardia executive, Edward M. Gillis, sold 3,257 shares of common stock for tax planning purposes.
Summary
- Edward M. Gillis, a Senior Vice President at BioCardia, Inc., sold 3,257 shares of common stock on December 20, 2024.
- The sale was executed at a price of $2 per share.
- Following the transaction, Mr. Gillis directly owns 8,968 shares of BioCardia common stock.
- The sale was conducted for tax planning purposes.
Sentiment
Score: 5
Explanation: The document is a neutral report of a routine stock sale by an executive for tax planning purposes, with no indication of positive or negative sentiment.
Management Comments
- The reported sale transactions were effected for tax planning purposes.
Industry Context
This is a routine filing related to insider trading and is common for executives of publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive stock sales.
- The sale is relatively small in volume and is not indicative of any major change in the company's outlook.
Stakeholder Impact
- The sale is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/20/2024 | Date of the stock sale transaction. |
| 12/26/2024 | Date the Form 4 was signed. |
Keywords
BioCardia, stock sale, insider trading, executive, share transaction, BCDA, tax planning
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.